MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

191.37 -13.16 (-6.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,812,935
Open 200.25
Bid (Size) 192.55 (400)
Ask (Size) 193.98 (100)
Prev. Close 204.53
Today's Range 189.49 - 205.00
52wk Range 119.18 - 205.97
Shares Outstanding 146,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗
Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam... 
Via MarketBeat
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill

Performance

YTD
+7.6%
+7.6%
1 Month
+6.9%
+6.9%
3 Month
-2.1%
-2.1%
6 Month
+16.2%
+16.2%
1 Year
+59.0%
+59.0%

More News

Read More
News headline image
Best Healthcare Stocks to Buy in 2026 ↗
Via The Motley Fool
Unusual volume S&P500 stocks in Thursday's session ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Discover the top S&P500 movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Via Investor Brand Network
Topics Intellectual Property
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
News headline image
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
From BioMedWire
Via GlobeNewswire
News headline image
3 Value Stocks We Approach with Caution
Via StockStory
News headline image
Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings ↗
Via Benzinga
News headline image
Why Biogen Stock Was a Winner on Wednesday ↗
Via The Motley Fool
News headline image
Biogen (BIIB) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales
Via StockStory
Topics Artificial Intelligence
News headline image
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks We Steer Clear Of
Via StockStory
News headline image
Biogen (BIIB) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Biogen (BIIB) Q3 2024 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen (BIIB) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen (BIIB) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Economy
News headline image
Stocks making big moves yesterday: Cadence Design Systems, JFrog, Lucid, Ulta, and Biogen
Via StockStory
Topics Economy Electric Vehicles
News headline image
3 Reasons to Avoid BIIB and 1 Stock to Buy Instead
Via StockStory
Topics Stocks

Frequently Asked Questions

Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 191.37
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 05/14/26 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 28.09B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 28B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story